Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study record content with a standard error screen. This indicates access is blocked rather than updated information for the study.SummaryDifference21%

- Check23 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page has been published.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a new revision of the page content. This change does not alter study details or visible information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe 'Other Study ID Numbers' section now includes '2018 ( U.S. NIH Grant/Contract )', indicating NIH funding for the study.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a newer revision of the study record on the ClinicalTrials.gov page.SummaryDifference0.0%

Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.